Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Orion Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Orion and Glykos Announce Research Collaboration for Next-Generation Adcs
Details : Under the agreement, Orion gains access to Glykos’ ADC technologies, initiating an ADC program and will be responsible for the target selection and commercialization of next-generation ADCs.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
January 08, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Orion Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?